These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14859591)

  • 1. [Inversion by ergotamine of hypotensive action of small doses of adrenalin in the dog].
    HAZARD R; BEAUVALLET M; GIUDICELLI R
    C R Seances Soc Biol Fil; 1951 Apr; 145(7-8):564-5. PubMed ID: 14859591
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of adrenaline and ergotamine on the oxygen consumption.
    LUNDHOLM L; MOHME E
    Acta Physiol Scand; 1949 Jan; 16(4):367-88. PubMed ID: 18128141
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of associated acetylcholine-atropine and acetylcholine-ergotamine on essential hypotension].
    RIVASI P
    Rass Neurol Veg; 1950 Jun; 8(2):138-49. PubMed ID: 14781409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Xanthic derivatives inhibiting the inversion by ergotamine of the hypotensor effects of isopropyladrenaline and of 3-4-dioxyephedrine].
    HAZARD R; BEAUVALLET M; GIUDICELLI R
    C R Seances Soc Biol Fil; 1951 Jan; 145(1-2):78-80. PubMed ID: 14839877
    [No Abstract]   [Full Text] [Related]  

  • 5. The antiadrenolytic action of ergotamine.
    KING TO; KOPPANYI T
    J Am Pharm Assoc Am Pharm Assoc; 1949 Jun; 38(6):346-8. PubMed ID: 18151713
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibitory effect of ergot alkaloids and their dihydro derivatives upon metabolic increase due to adrenalin].
    LINDNER A; BRAUNER F
    Z Vitam Horm Fermentforsch; 1949-1950; 3(3-4):278-87. PubMed ID: 14782635
    [No Abstract]   [Full Text] [Related]  

  • 7. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects.
    PETERS GA; HORTON BT
    Proc Staff Meet Mayo Clin; 1951 Apr; 26(9):153-61. PubMed ID: 14827944
    [No Abstract]   [Full Text] [Related]  

  • 8. Experiments with dihydro-ergotamine.
    VAN DONGEN K; DE BOER J
    Acta Brevia Neerl Physiol Pharmacol Microbiol E A; 1949; 17(1-4):39. PubMed ID: 15394593
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of prolonged ergotamine therapy; clinical study of a case of ergotamine therapy abnormally prolonged without toxic complications].
    SANGIORGI M
    Riforma Med; 1951 Jan; 65(1):4-9. PubMed ID: 14816994
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of ergotamine in the therapy of gastroduodenal ulcers].
    SCAFFIDI V
    Riv Gastroenterol; 1951; 3(1):1-10. PubMed ID: 14854683
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical value of ergotamine tests in electrocardiography].
    KISS A; SLAPAK L
    Wien Z Inn Med; 1951 Apr; 32(4):162-7. PubMed ID: 14836723
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of ergotamine tartrate on the normal electrocardiogram].
    RODRIGUEZ MI
    Arch Col Med El Salv; 1949 Sep; 2(3):153-76. PubMed ID: 15393999
    [No Abstract]   [Full Text] [Related]  

  • 13. Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine.
    PETERS GA; HORTON BT
    J Lab Clin Med; 1950 Dec; 36(6):972-3. PubMed ID: 14795057
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of caffeinated ergotamine tartrate in migraine attacks (E. C. 110 or cafergon); first results].
    GIRARD M
    Lyon Med; 1950 May; 183(22):345-8. PubMed ID: 15438042
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of caffeinated ergotamine tartrate in migraine attacks; E. C. 110 or cafergon; first results].
    GIRARD M
    J Med Chir Prat; 1950 Aug; 121(8):165-9. PubMed ID: 24538126
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of migraine and persistent headache with ergotamine tartrate and novocaine aerosols].
    TABART J
    Presse Med (1893); 1950 Nov; 58(76):1351-2. PubMed ID: 14797654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes effected by adrenalin and dihydroergotamine during the first phase of blood coagulation].
    LEIBETSEDER FJ
    Wien Z Inn Med; 1951 Mar; 32(3):102-70. PubMed ID: 14836714
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged vasoconstriction due to ergotamine tartrate.
    THOMPSON WS; McCLURE WW; LANDOWNE M
    Arch Intern Med (Chic); 1950 Apr; 85(4):691-98. PubMed ID: 15411251
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of ergotamine tartrate-caffeine in migraine attacks (EC 110 cafergon); first results].
    GIRARD M
    Arch Mal Appar Dig Mal Nutr; 1950; 39(9-10):1016-21. PubMed ID: 14790963
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative investigations on the effect of gynergen and hydergin on the electrocardiogram; contribution on possible applicability of the ergot test].
    ZEH E
    Z Kreislaufforsch; 1950 Nov; 39(21-22):675-84. PubMed ID: 14789117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.